Spots Global Cancer Trial Database for relapsed lymphoma
Every month we try and update this database with for relapsed lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma | NCT00086034 | Lymphoma Non-Hodgkin's L... | Motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma | NCT00054808 | Non-Hodgkin's L... Relapsed Lympho... Refractory Lymp... Low-Grade Lymph... Intermediate-Gr... | gallium nitrate | 18 Years - | Genta Incorporated | |
| Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin Lymphoma | NCT01900496 | Lymphoma | Brentuximab ved... Rituximab | 16 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Phase II Study of TAK228 in Relapsed Lymphoma | NCT02727777 | Lymphoma | TAK228 Blood Sugar Tes... | 18 Years - | M.D. Anderson Cancer Center | |
| Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors | NCT01929720 | Anxiety Disorde... Worry Uncertainty Sleep Disorders Insomnia Fatigue Pain Depression Cognitive-behav... Psychological I... Esophageal Canc... Pancreatic Canc... Leukemia Lung Cancer Multiple Myelom... Ovarian Neoplas... Stage III or IV... Stage IIIB, III... Glioblastoma Mu... Relapsed Lympho... Stage III or IV... Stage IIIC or I... | Cognitive-behav... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Autologous and Allogeneic Transplant for Relapsed Lymphoma | NCT00802113 | Non-Hodgkin's L... Hodgkins Diseas... | Fludarabine Busulfan Anti-Thymocyte ... | - 55 Years | Columbia University | |
| Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin Lymphoma | NCT01900496 | Lymphoma | Brentuximab ved... Rituximab | 16 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma | NCT00086034 | Lymphoma Non-Hodgkin's L... | Motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory Lymphoma | NCT02598570 | Lymphoma | duvelisib | 20 Years - 99 Years | AbbVie | |
| Autologous and Allogeneic Transplant for Relapsed Lymphoma | NCT00802113 | Non-Hodgkin's L... Hodgkins Diseas... | Fludarabine Busulfan Anti-Thymocyte ... | - 55 Years | Columbia University | |
| Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma | NCT00054808 | Non-Hodgkin's L... Relapsed Lympho... Refractory Lymp... Low-Grade Lymph... Intermediate-Gr... | gallium nitrate | 18 Years - | Genta Incorporated | |
| Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment. | NCT01022996 | Hodgkin Lymphom... | Everolimus (RAD... | 18 Years - | Novartis | |
| Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory Lymphoma | NCT02598570 | Lymphoma | duvelisib | 20 Years - 99 Years | AbbVie | |
| Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment. | NCT01022996 | Hodgkin Lymphom... | Everolimus (RAD... | 18 Years - | Novartis |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
